European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-19
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-18
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-17
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-16
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-15
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-14
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-13
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-12
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-11
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-10
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-09
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-08
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-07
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-06
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-05
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-04
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-03
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-02
European Society for Medical Oncology:
ESMO2014-Controversy-session-Endpoints-other-than-OS-01